Published • loading... • Updated
What to Know About OrbiMed's $39 Million Enliven Therapeutics Stock Sale Amid a 130% Rally
Summary by The Motley Fool
2 Articles
2 Articles
The Motley FoolReposted by 
BizToc
BizTocWhat to Know About OrbiMed's $39 Million Enliven Therapeutics Stock Sale Amid a 130% Rally
Key PointsOrbimed Advisors reported selling 860,123 shares of ELVN on June 22, 2026, generating a transaction value of approximately $39.0 million at an average price of $45.36 per share.This transaction represented 11.60% of Advisors Llc Orbimed's total indirect holdings, reducing indirect ownership from 7,415,225 to 6,555,102 shares.All shares were held indirectly via OrbiMed-managed entities.10 stocks we like better than Enliven Therapeutics …
·Alexandria, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
